Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Circulation Research|September 18, 2012
Translational success stories: development of direct thrombin inhibitorsMichiel Coppens, John W Eikelboom, David Gustafsson, et al.
Transfusion Medicine Reviews|June 26, 2017
Recognition and Management of Hemostatic Disorders in Critically Ill Patients Needing to Undergo an Invasive ProcedureMarcella C A Müller, Simon J Stanworth, Michiel Coppens, et al.
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisalStefano Barco, Jasper J Atema, Michiel Coppens, et al.
Blood|June 26, 2014
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsNick van Es, Michiel Coppens, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trialCedric Hermans, Michiel Coppens, Giuliana Ventriglia, et al.
European Heart Journal|February 27, 2014
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trialMichiel Coppens, David Synhorst, John W Eikelboom, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case seriesJoline L Saes, Britta A P Laros-van Gorkom, Michiel Coppens, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2024
[Hereditary thrombophilia; whom to test?]Kyra N Smit, Henrike M Hamer, Irene L M Klaassen, et al.
British Journal of Haematology|October 22, 2015
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrateStefano Barco, Y Whitney Cheung, Michiel Coppens, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2017
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysisMarjolein P A Brekelmans, Kim van Ginkel, Joost G Daams, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Circulation Research|September 18, 2012
Translational success stories: development of direct thrombin inhibitorsMichiel Coppens, John W Eikelboom, David Gustafsson, et al.
Transfusion Medicine Reviews|June 26, 2017
Recognition and Management of Hemostatic Disorders in Critically Ill Patients Needing to Undergo an Invasive ProcedureMarcella C A Müller, Simon J Stanworth, Michiel Coppens, et al.
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisalStefano Barco, Jasper J Atema, Michiel Coppens, et al.
Blood|June 26, 2014
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsNick van Es, Michiel Coppens, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trialCedric Hermans, Michiel Coppens, Giuliana Ventriglia, et al.
European Heart Journal|February 27, 2014
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trialMichiel Coppens, David Synhorst, John W Eikelboom, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case seriesJoline L Saes, Britta A P Laros-van Gorkom, Michiel Coppens, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2024
[Hereditary thrombophilia; whom to test?]Kyra N Smit, Henrike M Hamer, Irene L M Klaassen, et al.
British Journal of Haematology|October 22, 2015
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrateStefano Barco, Y Whitney Cheung, Michiel Coppens, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2017
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysisMarjolein P A Brekelmans, Kim van Ginkel, Joost G Daams, et al.
Pageof 15